Clinical and epidemiological profile of patients attendedat home care assistance in Aids – Vitória, ES – Brazil
Keywords:
profile, HIV, aids, home care, epidemiologyAbstract
Introduction: it’s extremely important the profile study of patients with HIV/AIDS for improvement of assistance, prevention and detection of faults.Objective:knowing clinical and epidemiological profile of HIV/AIDS patients attended in home care program of AIDS (ADT/AIDS). Method: retrospec-tive analyses of charts of patients attended in ADT/AIDS in Vitória metropolitan region. Result: the mean time from diagnostic of HIV until admissionwas 2.5 years, predominant exposition factors were: heterosexual (32.4%) and injecting drug users (28.7%). Locomotion difficulty was reason toADT/AIDS’ assistance in 80% of cases, related with neurotoxoplasmosis and wasting syndrom in 46.6% of times. During the assistance, 66.7% of patientsdidn’t need hospitalization. Before the admission, 47% of patients have been prescribed at least one antiretroviral therapy (HAART), and had changed thismore than two times in 43.5%. After admission, 21% of patients changed HAART more than two times in 27.3% of cases. The median time of staying inADT/AIDS was 64 days, and discharge from the program was for clinical improvement in 41.1% and deads in 49.4% of cases. Conclusion: this studyfound similar profile with the current epidemiology of AIDS that related with heterosexualization, impoverishment and bad level of schooling. Despite theavaliation happened after of HAART era, patients in ADT/AIDS had few time of diagnostic of HIV infection, but they had advanced disease. Therefore,ADT/AIDS have been good alternative of assistance in development countries, leading a reduction of hospitalization and it’s an important mean for com-pliance/adhesion to HAART.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2004 Janaina A.S. Casotti, Luciana N. Passos, Angela M.C.S. Silva, Simone S.F. Tosi, Tânia Q.R. Motta

This work is licensed under a Creative Commons Attribution 4.0 International License.







